Emeryville, CA – According to filings with the U.S. Securities and Exchange Commission, Metagenomi Technologies is raising $175,374,794.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brian Thomas played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Metagenomi Technologies
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases. We are discovering breakthrough gene editing systems from nature to develop next generation therapies for patients. Harnessing the power of metagenomics to unlock 4 billion years of microbial evolution. We search the Earths natural environment to fuel the largest and most diverse toolbox of gene editing systems for therapeutics development.

To learn more about Metagenomi Technologies, visit http://www.metagenomi.co/

Contact:
Brian Thomas, Chief Executive Officer
510-878-6868
https://www.linkedin.com/in/b-c-thomas/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved